The Cooper Companies, Inc. logo
The Cooper Companies, Inc. (COO)
Compare

COO Cash Flow Statement

Operating, investing, and financing cash flow analysis

COO Quarterly Cash Flow Statement (USD)

Quarterly ReportTTM
04/30/2026
01/31/2026
10/31/2025
07/31/2025
04/30/2025
01/31/2025
10/31/2024
07/31/2024
953.000M182.800M260.900M247.900M261.400M96.200M190.600M268.100M207.500M
235.800M-77.900M130.800M84.600M98.300M87.700M104.300M117.500M104.700M
384.700M95.400M95.500M98.400M95.400M92.600M91.000M91.000M89.000M
0.000.000.000.000.000.000.000.000.00
Change in Accounts Receivable
3.238B809.200M807.100M829.000M792.300M780.900M716.400M717.000M739.000M
Change in Inventory
Change in Accounts Payable
Change in Working Capital
11.900M91.600M-36.100M-25.100M-18.500M-165.600M-75.600M-31.200M-49.800M
Cash from Investing
-383.500M-86.400M-102.200M-98.000M-96.900M-78.100M-89.400M-140.000M-89.000M
-14.100M-3.600M0.00-10.500M0.000.000.00-343.400M0.00
Cash from Financing
Debt Repayment
-357.500M-15.500M-92.500M-196.800M-52.700M-40.600M0.000.000.00
0.000.000.000.000.000.000.000.000.00
569.500M96.400M158.700M149.900M164.500M18.100M101.200M128.100M118.500M
Net Change in Cash
22.700M14.000M14.300M-14.300M8.700M15.200M-6.700M-2.100M-2.800M

COO Annual Cash Flow Statement (USD)

Annual Report
10/31/2025
10/31/2024
10/31/2023
10/31/2022
10/31/2021
10/31/2020
10/31/2019
10/31/2018
796.100M709.300M607.500M692.400M738.600M486.600M713.200M668.900M
374.900M392.300M294.200M385.800M2.945B238.400M466.700M139.900M
423.000M375.100M367.700M346.100M309.300M287.100M280.800M275.100M
0.000.000.000.000.000.0035.100M43.200M
Change in Accounts Receivable
829.000M717.000M609.700M557.800M515.300M435.400M435.300M374.700M
Change in Inventory
Change in Accounts Payable
Change in Working Capital
-284.800M-333.700M-218.800M-174.000M-149.900M-125.800M-40.100M119.600M
Cash from Investing
-362.400M-421.200M-392.500M-242.000M-214.400M-310.400M-292.100M-193.600M
-10.500M-343.400M-56.500M-1.589B0.000.000.000.00
Cash from Financing
Debt Repayment
-290.100M0.000.00-78.500M-24.800M-47.800M-156.100M0.00
0.000.00-3.000M-3.000M-3.000M-3.000M-3.000M-2.900M
433.700M288.100M215.000M450.400M524.200M176.200M421.100M475.300M
Net Change in Cash
2.900M-13.200M-17.700M42.300M-20.500M27.300M11.800M-11.100M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About The Cooper Companies, Inc.

The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.

San Ramon, CA
16,000 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Albert G. White